Steve Mennen
Vice President, Pre-Clinical Development @ Accent Therapeutics
5p99f7u@gg3kh7uw.5d5
Sign up to see email
Known information
- Holds a PhD
- Has a background in pre-clinical development
About Accent Therapeutics
Accent Therapeutics, based in Lexington, MA, develops small molecule therapeutics targeting RNA-modifying proteins for cancer treatment. The company has a partnership with AstraZeneca and has raised $75 million in Series C financing.